Mary Sandford

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Enhancing the clinical value of serum neurofilament light chain measurement”.

Enhancing the clinical value of serum neurofilament light chain measurement

JCI Insight(2022)10.1172/jci.insight.161415

N/A

0.780DataRank · unranked

20 citations

Ruturaj Masvekar, Mika Komori, Jonathan A. Phillips, Vighnesh Ramesh, Mihael Varosanec +3 more

Idebenone does not inhibit disability progression in primary progressive MS

Multiple Sclerosis and Related Disorders(2020)10.1016/j.msard.2020.102434

N/A

0DataRank · unranked

32 citations

Tianxia Wu, Jonathan A. Phillips, Mika Leinonen, Ruturaj Masvekar, Mika Komori +4 more

Machine learning-optimized Combinatorial MRI scale (COMRISv2) correlates highly with cognitive and physical disability scales in Multiple Sclerosis patients

medRxiv(2021)10.1101/2021.03.26.21254405

N/A

0DataRank · unranked

6 citations

Mihael Varosanec, Péter Kósa, Mary Sandford, Vesna Prchkovska, David Moreno‐Dominguez +2 more

Superiority of serum NFL in predicting Multiple Sclerosis severity

medRxiv(2021)10.1101/2021.05.07.21256836

N/A

0DataRank · unranked

0 citations

Ruturaj Masvekar, Mika Komori, Jonathan A. Phillips, Vighnesh Ramesh, Mihael Varosanec +3 more

Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanisms

Nature Communications(2022)10.1038/s41467-022-35357-4

N/A

0DataRank · unranked

30 citations

Christopher Barbour, Mihael Varosanec, Alison Wichman, Mary Sandford, Mark Greenwood +2 more